Robbie Alton is the founder of OnKure Therapeutics. OnKure Therapeutics has raised $222M in total funding. Latest round: Growth.
Robbie Alton is the Vice President of Clinical Operations at OnKure Therapeutics, a clinical-stage biopharmaceutical company based in Boulder, Colorado. The company focuses on discovering and developing oncology precision medicines. Alton brings nearly two decades of global clinical development and operations experience, primarily within the oncology field.
Full founder directory · Investor directory · Company funding database · Fundraising library